Epstein Secrets

g two full doses one month apart was 62% effective." Combined, the data indicated "an average efficacy rate of 70%." Reuters (11/23, Smout, Kelland, Burger) reports AstraZeneca "said it was a minor mistake that made the team realise how they could significantly boost the shot's success rate, to as much

nternationally recognized borders of Azerbaijan." This "also reflected the wider outrage at the cease-fire in Armenia and among ethnic Armenians in Nagorno-Karabakh, raising further questions about whether the pact can hold despite nearly 2,000 Russian peacekeepers deployed to enforce it." Israeli PM Reportedly

Azerbaijan Territory. The Washington Post (11/22, Cookman, Dixon, 14.2M) reports, "For Armenian soldiers on the losing side of the short but brutal Nagorno-Karabakh war, the loss of territory to Azerbaijan remains so bitter that some say they would have preferred to fight on." The "sting of the Moscow-brokered

.com/article/us-health-coronavirus-brazil-vaccine/astrazeneca-covid-19-vaccine- trial-brazil-volunteer-dies-trial-to-continue-idUSICBN2762MO> (10/21, Burger) reports that "a source familiar with the matter told Reuters that the trial would have been suspended if the volunteer who died had received the C

er Nikol Pashinyan "said...he saw no possibility of a diplomatic solution at this stage in the conflict with Azerbaijan over the mountain enclave of Nagorno-Karabakh." Pashinyan's comments, "after Azerbaijan's president said he believed the conflict could be solved militarily, increased doubts over a diplomatic

ealth- coronavirus-astrazeneca-oxford/decades-of-work-and-half-a-dose-of-fortune-drove-oxford-vaccine-success- idUSKBN2832NC> (11/23, Smout, Kelland, Burger) reports AstraZeneca "said it was a minor mistake that made the team realise how they could significantly boost the shot's success rate, to as much

6-21352-11eb-9c21-3cc501d0981f story.html> (11/22, Cookman, Dixon, 14.2M) reports, "For Armenian soldiers on the losing side of the short but brutal Nagorno-Karabakh war, the loss of territory to Azerbaijan remains so bitter that some say they would have preferred to fight on." The "sting of the Moscow-brokered

dy in Brazil. ... Its trial here in the US was put on hold last month after a volunteer in Europe developed neurological symptoms." Reuters (10/21, Burger) reports that "a source familiar with the matter told Reuters that the trial would have been suspended if the volunteer who died had received the CO

r Nikol Pashinyan "said...he saw no possibility of a diplomatic solution at this stage in the conflict with Azerbaijan over the mountain enclave of Nagorno-Karabakh." Pashinyan's comments, "after Azerbaijan's president said he believed the conflict could be solved militarily, increased doubts over a diplomatic